Performance/Satisfaction
ExaStim makes everyday tasks like bathing, grooming and eating easier, making it possible for people with spinal cord injuries to live more independently. Results from ANEUVO clinical studies show lasting impacts that go beyond treatment:
8 out of 10 patients continue to experience improved ability to manage everyday life tasks, even after therapy ends.*
*Results from the ASPIRE Study.
Dexterity
What could improved hand dexterity mean for you? Results from ANEUVO clinical studies show 85% of patients experienced an improvement in dexterity of one or both hands that was sustained even 4 weeks after cessation of treatment.* Building dexterity can make it easier to manage daily tasks like writing, dressing and housekeeping—leading to greater independence.
*Results from the ASPIRE Study. According to performance on 9-Hole Peg Test.
Data based on analysis of Modified Intent-to-Treat (MITT), treatment as administered population.
Sensory
Touch sensation in the hand is important for preventing injuries, performing daily tasks, and feeling connected. Clinical studies have shown improvement in touch sensation for people who use ExaStim: At the completion of treatment, clinical evaluations showed a measurable increase in light touch sensation of the hand.
*Results from ASPIRE Study. According to ISNCSCI light touch subscores of C6-T1.
Satisfaction
We’re excited about the results of our clinical trials–and our patients are, too.
*Results from the ASPIRE Home Study.
*Results from the ASPIRE Home Study.
Safety
The Company
U.S. market entry furthers global mission for accessible clinical and at-home non-invasive neuromodulation therapy Los Angeles, CA, April 16, 2026 (GLOBE NEWSWIRE) -- ANEUVO, a...
Read more
U.S. market entry furthers global mission for accessible clinical and at-home non-invasive neuromodulation therapy Los Angeles, CA, April 16, 2026 (GLOBE NEWSWIRE) -- ANEUVO, a...
Read more
EASTHAMPTON, MA (WGGB/WSHM) -- Nearly a decade after a training ride crash left him with a spinal cord injury, an Easthampton man is regaining function...
Read more
Proceeds to support manufacturing growth, regulatory advancement, and disciplined commercialization expansion Los Angeles, CA, March 05, 2026 (GLOBE NEWSWIRE) -- ANEUVO, a medical technology company...
Read more
Honor highlights international startup advancing non-invasive rehabilitation technology for people living with chronic spinal cord injury Los Angeles, CA, Feb. 11, 2026 (GLOBE NEWSWIRE) --...
Read more
The first MDR-Approved Non-Invasive Spinal Stimulation System in Europe Los Angeles, CA, Sept. 16, 2025 (GLOBE NEWSWIRE) -- ANEUVO today announced its participation in two...
Read more
Key Milestone Signals Readiness for European Market Entry and Commitment to Quality Los Angeles, CA, April 09, 2025 (GLOBE NEWSWIRE) -- ANEUVO, a pioneer in...
Read more
This new phase of clinical research will test the safety and feasibility of ANEUVO’s non-invasive therapy for future use by individuals living with chronic spinal...
Read more[1] Christopher & Dana Reeve Foundation. (n.d.). Statistics about paralysis. Retrieved from https://www.christopherreeve.org/todays-care/paralysis-help-overview/stats-about-paralysis
[2] Taylor C, McHugh C, Mockler D, Minogue C, Reilly RB, Fleming N. (2021) Transcutaneous spinal cord stimulation and motor responses in individuals with spinal cord injury: A methodological review. PLoS One. 2021 Nov 18;16(11):e0260166.
